Wednesday, November 25, 2009, 10:33am EST - Canadian Markets close in 5 hours and 27 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Inverness Medical Innovations Inc. (IMA)

At 10:17 EST: 42.34 USD  Up 0.23 (0.55%)  
MORE ON IMA
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials
Profile Get Profile for:
Inverness Medical Innovations Inc.
51 Sawyer Road
Suite 200
Waltham, MA 02453-3448
Phone: 781-647-3900
Fax: 781-647-3939
Web Site: http://www.invernessmedical.com

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Medical Laboratories & Research
Employees (last reported count): 8,300

BUSINESS SUMMARY
Inverness Medical Innovations, Inc. engages in the development, manufacture, and marketing of consumer and professional medical diagnostic products, as well as a range of vitamins and nutritional supplements. The company’s Professional Diagnostics segment offers preventive and interventional medical test products in the areas, such as cardiology, women's health, oncology, infectious disease, and drugs of abuse. Its Health Management segment provides wellness programs, including health and productivity assessment, healthy living programs, health portal and personal health record, and health coaching and risk screenings; disease management program; oncology program; and obstetrical care services, and home-based obstetrical programs. The company’s Consumer Diagnostics segment offers a range of consumer products, including home diagnostic tests, cholesterol tests, glucose products, and treatment for bacterial vaginosis. Its vitamins and Nutritional Supplements segment offers vitamins and nutritional supplements, including Stresstabs, a B-complex vitamin with added antioxidants; Ferro-Sequels, a time-release iron supplement; Protegra, an antioxidant vitamin and mineral supplement; Posture-D, a calcium supplement; SoyCare, a soy supplement for menopause; ALLBEE, a line of B-complex vitamins; and Z-BEC, a zinc supplement with B-complex vitamins and added antioxidants. The company sells and markets its products through sales forces, distributors, and channel partners to hospitals, reference laboratories, physicians’ offices and other point-of-care settings, self-insured employers, pharmaceutical companies, retail drug stores, groceries, mass merchandisers, and warehouse clubs. It has operations in the United States, Canada, the United Kingdom, Germany, Italy, Spain, the Netherlands, France, Austria, India, Japan, China, Australia, South Africa, Brazil, Colombia, and Israel. The company was founded in 2001 and is headquartered in Waltham, Massachusetts.
Key Statistics

COMPANY WEBSITES
  • Home Page
  • Search Yahoo! for:
    More on Inverness Medical Innovations Inc.



    View Financials

    OFFICERS
      Pay Exercised
    Mr. Ron Zwanziger , 55
    Chairman, Chief Exec. Officer and Pres
    $ 824.00K $ 0
    Mr. David Teitel , 45
    Chief Financial Officer and Principal Accounting Officer
    $ 299.00K $ 0
    Dr. Ronald D. Geraty M.D., 62
    Chief Exec. Officer of Alere Medical Inc
    $ 663.00K $ 2.78M
    Dr. David Scott Ph.D., 52
    Chief Technical Officer, Chief Scientific Officer
    $ 622.00K $ 0
    Dr. Jerry McAleer Ph.D., 53
    VP of R&D, VP of Cardiology
    $ 553.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
    Get Profile for Another Symbol:
    Symbol Lookup
    Latest News Canadian Indices